Authored by Jack Phillips via The Epoch Times (emphasis ours),The American College of Cardiology recently released recommendations indicating that inflammation should be considered when trying to predict heart disease. A man walks in a hospital hallway in Irvine, Calif., on Oct. 11, 2016. It is referring to low-density lipoprotein that is sometimes called “bad” cholesterol, and statins, meanwhile, are a class of drugs that are used to lower cholesterol in the blood. A type of monoclonal antibody called canakinumab has been shown to reduce major adverse cardiovascular events, they said. The researchers noted that some anti-inflammatory drugs such as methotrexate, corticosteroids, and TNF inhibitors have not shown benefits in major trials .